Editorial
 RULES FOR STEM CELL RESEARCH   
 Thursday, March 06, 2014 
 After more than a decade of research on the use of stem cell technology for treating deadly human diseases, no breakthrough has been achieved in commercial applications of this science worldwide. 
  Past Editorial...  
TODAY'S NEWS
16:00  [IST]Alkermes begins pivotal clinical development programme for ALKS 5461 to treat major depressive disorder
15:00  [IST]Pluristem receives US FDA approval for manufacturing of PLX cell products
14:00  [IST]Biodel signs manufacturing agreement with Emergent for glucagon rescue product
13:00  [IST]Alcobra to initiate phase 3 trial of Metadoxine in adult patients with ADHD
12:00  [IST]Colder expands MPC/MPX back-to-back adapters product offering for single-use bioprocessing
11:00  [IST]Aveed injection approved in US for treatment of adult men with hypogonadism
more news >>
TOP NEWS
08:00  [IST]InnAccel plans startup ecosystem with 6 month fellowship programme on affordable innovation in medical technology
08:00  [IST]Health Min slams media reports against DCGI office as 'baseless' and 'harmful'
08:00  [IST]Role of pharmacists in detecting risks of drugs as important as that of medical consultants: Dr Pawar
08:00  [IST]APPCB steps to curb discharge of effluents into lakes surrounding Hyderabad giving results
08:00  [IST]Maha FDA cancels license of C&F agent for violation of DPCO
08:00  [IST]Health ministry to go ahead with plans to begin rural medical course; not to impose on all states
more news >>
YESTERDAY'S NEWS
18:00  [IST]US FDA grants fast track designation to Tekmira's anti-Ebola viral therapeutic
17:00  [IST]Genmab's partner Janssen to initiate phase III study of daratumumab in relapsed or refractory multiple myeloma
16:30  [IST]Waters Acquity QDa Detector wins Pittcon Award
16:15  [IST]ReeLabs to expand stem cell operations in Karantaka to set up facility and invest Rs.50 crore
16:00  [IST]Boehringer Ingelheim's AF drug, Pradaxa receives approval from Jordan FDA
15:00  [IST]Pfizer recalls 2 lots of Effexor XR 150 mg, one lot of Greenstone's Venlafaxine HCI 150 mg
more news >>
INTERVIEW  
Knowledge empowerment of pharmacist would drive to achieve Pharma Vision 2020
DA Gundu Rao, president of KSPC
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is former Karnataka DC Jagashetty's demand to create IDS on the lines of IAS to create new band of qualified drug personnel to man the drug regulatory system justified?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |